Marzano AV, Ishak RS, Saibeni S, et al. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 2013 (Epub ahead of print). 3. Marzano AV, Cugno M, Trevisan V, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010;162:100–7.PubMedCrossRef 4. Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma gangrenosum: Selleck JAK inhibitor clinical and experimental observations in five cases occurring in adults. Arch Epigenetics inhibitor Dermatol Syphilol. 1930; 22:655–80. 5. Ruocco E, Sangiuliano S, Gravina AG, et al. Pyoderma gangrenosum:
an updated review. J Eur Acad Dermatol Venereol. 2009;23:1008–17.PubMedCrossRef 6. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34:395–409.PubMedCrossRef 7. Marzano AV, Tourlaki A, Alessi E, et al. Widespread this website idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab.
Clin Exp Dermatol. 2008;33:156–9.PubMedCrossRef 8. Lyon CC, Smith AJ, Beck MH, et al. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol. 2000;42:992–1002.PubMedCrossRef 9. Marzano AV, Ishak RS, Lazzari R, et al. Vulvar pyoderma gangrenosum with renal involvement. Eur J Dermatol. 2012;22:537–9.PubMed 10. McAleer MA, Powell FC, Devaney D, et al. Infantile pyoderma gangrenosum. J Am Acad Dermatol. 2008;58:S23–8.PubMedCrossRef 11. Poiraud C, Gagey-Caron V, Barbarot S, et al. Cutaneous, mucosal and systemic pyoderma gangrenosum. Ann Dermatol Venereol. 2010;137:212–5.PubMedCrossRef 12. Cullen TS. A progressively enlarging ulcer of the abdominal wall involving the skin and fat, following drainage of an abdominal abscess apparently of appendiceal origin. Surg Gynecol Obstet. 1924;38:579–82. 13. Schöfer H, Baur SJ. Successful treatment of postoperative GBA3 pyoderma gangrenosum with
cyclosporin. Eur Acad Dermatol Venereol. 2002;16:148–51.CrossRef 14. Ouazzani A, Berthe JV, de Fontaine S. Post-surgical pyoderma gangrenosum: a clinical entity. Acta Chir Belg. 2007;107:424–8.PubMed 15. Gooding JM, Kinney TB, Oglevie SB, et al. Pyoderma gangrenosum twice complicating percutaneous intervention in a single patient. AJR Am J Roentgenol. 1999;172:1352–4.PubMedCrossRef 16. Duguid CM, Powell FC. Pyoderma gangrenosum. Clin Dermatol. 1993;11:129–33.PubMedCrossRef 17. Ho K, Otridge BW, Vanderberg E, et al. Pyoderma gangrenosum, polycythemia rubravera, and the development of leukemia. J Am Acad Dermatol. 1992;27:804–8.PubMedCrossRef 18. Swale VJ, Saha M, Kapur N, et al. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab. Clin Exp Dermatol. 2005;30:134–6.PubMedCrossRef 19. Walsh M, Leonard N, Bell H.